Michael Kishbauch
2012
In 2012, Michael Kishbauch earned a total compensation of $3M as Director, Former President and Chief Executive Officer Retired at Achillion Pharmaceuticals, a 111% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $292,338 |
|---|---|
| Option Awards | $2,225,721 |
| Salary | $470,300 |
| Other | $7,833 |
| Total | $2,996,192 |
Kishbauch received $2.2M in option awards, accounting for 74% of the total pay in 2012.
Kishbauch also received $292.3K in non-equity incentive plan, $470.3K in salary and $7.8K in other compensation.
Rankings
In 2012, Michael Kishbauch's compensation ranked 2,336th out of 11,487 executives tracked by ExecPay. In other words, Kishbauch earned more than 79.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,336 out of 11,487 | 80th |
Division Manufacturing | 810 out of 4,252 | 81st |
Major group Chemicals And Allied Products | 181 out of 1,200 | 85th |
Industry group Drugs | 105 out of 922 | 89th |
Industry Pharmaceutical Preparations | 85 out of 697 | 88th |
Source: SEC filing on April 18, 2014.
Kishbauch's colleagues
We found four more compensation records of executives who worked with Michael Kishbauch at Achillion Pharmaceuticals in 2012.
2012
Gautam Shah
Achillion Pharmaceuticals
Former Executive Vice President and Chief Compliance Officer
2012
Milind Deshpande
Achillion Pharmaceuticals
Chief Executive Officer
2012
Mary Fenton
Achillion Pharmaceuticals
Chief Financial Officer
2012
Joseph Truitt
Achillion Pharmaceuticals